X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4948) 4948
Book Review (674) 674
Publication (340) 340
Newsletter (98) 98
Book Chapter (18) 18
Conference Proceeding (8) 8
Magazine Article (8) 8
Book / eBook (4) 4
Dissertation (3) 3
Newspaper Article (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4490) 4490
humans (3401) 3401
male (2230) 2230
thiophenes - pharmacology (1814) 1814
animals (1793) 1793
female (1769) 1769
thiophenes - therapeutic use (1663) 1663
middle aged (1140) 1140
thiophenes - administration & dosage (1025) 1025
aged (910) 910
pharmacology & pharmacy (904) 904
thiophenes - adverse effects (846) 846
adult (828) 828
rats (813) 813
treatment outcome (655) 655
rivaroxaban (630) 630
mice (612) 612
thiophene (584) 584
dose-response relationship, drug (566) 566
thiophenes - pharmacokinetics (454) 454
prasugrel hydrochloride (434) 434
administration, oral (432) 432
analysis (421) 421
double-blind method (415) 415
abridged index medicus (412) 412
thiophenes - chemistry (397) 397
double-blind (360) 360
hematology (359) 359
drug therapy (358) 358
peripheral vascular disease (355) 355
duloxetine hydrochloride (352) 352
cardiac & cardiovascular systems (333) 333
time factors (328) 328
morpholines - therapeutic use (322) 322
thiophenes (315) 315
blood pressure - drug effects (311) 311
anticoagulants - therapeutic use (300) 300
dabigatran (300) 300
ticlopidine - analogs & derivatives (296) 296
anticoagulants (294) 294
research (277) 277
rats, sprague-dawley (271) 271
care and treatment (267) 267
pharmacokinetics (263) 263
clopidogrel (262) 262
chemistry, medicinal (259) 259
biochemistry & molecular biology (255) 255
medicine & public health (255) 255
thiophenes - blood (246) 246
morpholines - administration & dosage (245) 245
risk factors (242) 242
drug therapy, combination (241) 241
piperazines - therapeutic use (231) 231
prevention (231) 231
beta-alanine - analogs & derivatives (230) 230
morpholines - adverse effects (230) 230
safety (229) 229
aged, 80 and over (226) 226
anticoagulants - administration & dosage (226) 226
disease models, animal (223) 223
anticoagulants - adverse effects (222) 222
medicine, general & internal (222) 222
prasugrel (220) 220
platelet aggregation - drug effects (219) 219
structure-activity relationship (216) 216
endocrinology & metabolism (214) 214
efficacy (211) 211
platelet aggregation inhibitors - therapeutic use (210) 210
duloxetine (209) 209
hypertension (205) 205
blood platelets - drug effects (203) 203
oncology (202) 202
venous thromboembolism (202) 202
neurosciences (201) 201
adolescent (196) 196
in-vitro (194) 194
factor xa inhibitors (193) 193
rats, wistar (193) 193
drug interactions (192) 192
diabetes mellitus, type 2 - drug therapy (191) 191
internal medicine (190) 190
hemorrhage - chemically induced (187) 187
clinical trials as topic (185) 185
health aspects (182) 182
toxicology (182) 182
acute coronary syndromes (179) 179
prospective studies (176) 176
diabetes (175) 175
inhibition (175) 175
article (174) 174
drug administration schedule (174) 174
hypertension - drug therapy (174) 174
therapy (173) 173
warfarin (172) 172
young adult (172) 172
cancer (171) 171
expression (171) 171
pharmacology (170) 170
thiophenes - chemical synthesis (169) 169
clinical trials (168) 168
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4848) 4848
German (83) 83
French (42) 42
Russian (25) 25
Japanese (22) 22
Spanish (14) 14
Chinese (13) 13
Italian (10) 10
Hungarian (4) 4
Polish (4) 4
Czech (2) 2
Romanian (2) 2
Dutch (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 12/2013, Volume 163, Issue 5, pp. 666 - 673
There is increasing recognition that thrombotic complications may occur in patients with cirrhosis, and literature on antithrombotic treatment in these... 
anticoagulants | antithrombin | coagulation | anti‐Xa assay | cirrhosis | Anti-Xa assay | Anticoagulants | Cirrhosis | Antithrombin | Coagulation | anti-Xa assay | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | LIVER-DISEASE | HEMATOLOGY | HEMOSTASIS | Thiophenes - therapeutic use | Heparin, Low-Molecular-Weight - pharmacology | Polysaccharides - blood | Factor Xa Inhibitors | beta-Alanine - blood | Humans | Middle Aged | Heparin - therapeutic use | Male | Dabigatran | Drug Monitoring - methods | Morpholines - blood | Heparin, Low-Molecular-Weight - therapeutic use | Thiophenes - blood | Thrombophilia - etiology | Antithrombins - pharmacology | Rivaroxaban | Heparin, Low-Molecular-Weight - blood | Sensitivity and Specificity | beta-Alanine - pharmacology | Prothrombin - antagonists & inhibitors | Female | beta-Alanine - analogs & derivatives | Benzimidazoles - blood | Heparin - pharmacology | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Polysaccharides - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - complications | beta-Alanine - therapeutic use | False Negative Reactions | Morpholines - pharmacology | Thiophenes - pharmacology | Liver Cirrhosis - blood | Polysaccharides - pharmacology | Anticoagulants - blood | Diagnostic Tests, Routine | Blood Coagulation - drug effects | Thrombophilia - blood | Anticoagulants - pharmacology | Antithrombins - blood | Blood Coagulation Tests | Heparin - blood | Benzimidazoles - pharmacology | Liver cirrhosis | Anticoagulants (Medicine) | Index Medicus
Journal Article
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 05/2016, Volume 86, Issue 19, pp. 1785 - 1793
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2012, Volume 10, Issue 10, pp. 1999 - 2005
Background:  Post‐treatment platelet reactivity (PR) is associated with ischemic and bleeding events in patients receiving P2Y12 receptor antagonists.... 
Vasodilator‐Stimulated Phosphoprotein index | bleedings | platelet monitoring | stent thrombosis | P2Y12‐ADP receptor antagonist | P2Y12-ADP receptor antagonist | Stent thrombosis | Vasodilator-Stimulated Phosphoprotein index | Platelet monitoring | Bleedings | THERAPEUTIC WINDOW | DEFINITION | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | STENT PLACEMENT | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | BLOOD-TRANSFUSION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ACTIVE METABOLITE | Prasugrel Hydrochloride | Predictive Value of Tests | Thiophenes - therapeutic use | Prospective Studies | Follow-Up Studies | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Receptors, Purinergic P2Y12 - drug effects | Male | Purinergic P2Y Receptor Antagonists - adverse effects | Phosphoproteins - blood | Receptors, Purinergic P2Y12 - blood | Time Factors | Coronary Thrombosis - prevention & control | Odds Ratio | Coronary Thrombosis - blood | Platelet Aggregation Inhibitors - adverse effects | Risk Assessment | Risk Factors | Myocardial Ischemia - prevention & control | Piperazines - therapeutic use | Piperazines - adverse effects | Blood Platelets - metabolism | Acute Coronary Syndrome - therapy | Coronary Thrombosis - etiology | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Multivariate Analysis | Thiophenes - adverse effects | Acute Coronary Syndrome - mortality | Microfilament Proteins - blood | Platelet Function Tests | Female | Myocardial Ischemia - mortality | Platelet Aggregation - drug effects | Blood Platelets - drug effects | France | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Cell Adhesion Molecules - blood | Coronary Thrombosis - mortality | Kaplan-Meier Estimate | Myocardial Ischemia - blood | Proportional Hazards Models | Linear Models | Treatment Outcome | Acute Coronary Syndrome - blood | Myocardial Ischemia - etiology | Transluminal angioplasty | Coronary heart disease | Vasodilators | Analysis | Cardiac patients | Index Medicus
Journal Article
Circulation Research, ISSN 0009-7330, 07/2014, Volume 115, Issue 3, pp. 388 - 399
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 05/2015, Volume 139, Issue 5, pp. 665 - 673
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2012, Volume 18, Issue 22, pp. 6239 - 6248
Journal Article
Anesthesiology, ISSN 0003-3022, 01/2012, Volume 116, Issue 1, pp. 94 - 102
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 03/2015, Volume 17, Issue 3, pp. 294 - 303
Aims: The long-term efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, was evaluated over 104 weeks in patients aged 55-80... 
phase | study | type 2 diabetes | inhibitor | SGLT2 | canagliflozin | III | Phase III study | Type 2 diabetes | Canagliflozin | SGLT2 inhibitor | GLYCEMIC CONTROL | PLACEBO | BACKGROUND METFORMIN | ADD-ON | SITAGLIPTIN | MELLITUS | phase III study | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | POOLED ANALYSIS | GLIMEPIRIDE | INHIBITOR | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Male | Osmolar Concentration | Urinary Tract Infections - chemically induced | Aged, 80 and over | Cholesterol, LDL - blood | Female | Glucosides - therapeutic use | Blood Pressure - drug effects | Metformin - administration & dosage | Glucosides - adverse effects | Hypoglycemic Agents - therapeutic use | Fasting | Double-Blind Method | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Diuresis - drug effects | Cholesterol, HDL - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Mycoses - chemically induced | Glucose metabolism | Low density lipoproteins | Mycoses | Hemoglobin | Urinary tract infections | Blood lipids | Glucose | Dextrose | Medical research | Blood pressure | Diabetes | Cholesterol | Index Medicus
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 10/2013, Volume 111, Issue 2, pp. 273 - 278
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 07/2017, Volume 69, Issue 7, pp. 1495 - 1501
Journal Article